| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Food Science and Human Nutrition Department, University of Florida, Gainesville.
2 Supported in part by the Florida Agricultural Experiment Station (Journal Series no. R-08521) and NIH grant DK56274. 3 Address reprint requests to JF Gregory III, Food Science and Human Nutrition Department, PO Box 110370, Gainesville, FL 32611-0370. E-mail: jfgy{at}ufl.edu.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
100 µg/d and that the risk of intakes > 1000 µg/d (the FDA’s safe upper limit of daily intake) would be minimal, its actual effect on folate intake has yet to be determined. Objective: The objective was to estimate the effect of folic acid fortification on the amount of folate consumed by persons in the United States.
Design: Linear regression analysis of data from published studies was used to determine the relation between a chronic folic acid dose and the resulting increase in steady state concentrations of folate in plasma or serum. Using this regression equation and reverse prediction, we quantified the increase in folic acid intake from fortification required to achieve the increase in plasma or serum folate observed in published studies.
Results: The increase in circulating folate concentration was linearly related to folic acid intake over the range of 100–1000 µg/d (r = 0.984, P < 0.0001). Predicted increases in folic acid intake from fortified food ranged from 215 to 240 µg/d.
Conclusions: Typical intakes of folic acid from fortified foods are more than twice the level originally predicted. The effect of this much higher level of fortification must be carefully assessed, especially before calls for higher levels of fortification are considered.
Key Words: Food fortification • folic acid • folate • neural tube defects • nutrition
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
The success of fortification was quickly seen (1) with the declining incidence of folate deficiency (plasma concentration < 3 ng/mL, or 6.8 nmol/L) and a concurrent decrease in the incidence of elevated (> 13 µmol/L) plasma total homocysteine, a biochemical marker of folate deficiency. Of possibly greater import was the 19% decrease in the incidence of NTD since the onset of fortification (6).
Initial estimates by the Food and Drug Administration (FDA) anticipated an increase in folate intake by adults of between 70 and 130 µg/d (2) depending on age and consumption patterns. Nonetheless, much evidence suggests that the nutritional and health benefits of current fortification practices may be due to an increase in folate consumption greater than that predicted by the FDA model (7–9). Yet, despite the ubiquitous nature of fortified foods and foods containing ingredients with added folic acid (eg, enriched flour) in the United States, no determination of the effect of fortification on actual folate consumption has been made.
In light of this lack of information on the true nature of the increase in folic acid consumption, we propose that it is possible to estimate the intake indirectly from existing data. Specifically, by comparing the change in folate status achieved through fortification with that achieved by controlled oral folic acid administration, novel information can be derived on how typical daily folate consumption increased with the introduction of fortification.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
200 µg folic acid/d is consumed (10), whereas a 12–14-wk intervention is required when 
400 µg folic acid/d is consumed (10,11). Thus, intervention studies of shorter duration than these periods were excluded on the basis that serum or plasma folate concentrations may not have reached a plateau (10–12). We plotted the change in serum or plasma folate concentration against daily folic acid consumption and fitted a linear regression line to the plot. Geometric mean or median concentrations were used because folate and total homocysteine concentrations are not normally distributed (1,13).
Observational studies: determining the effect of folic acid fortification on serum and plasma folate concentrations
A literature review was conducted to identify studies in which serum or plasma folate concentrations were measured within the same population group before folic acid fortification and again after fortification. With the use of reverse prediction, comparing the postfortification changes in serum or plasma folate concentrations to the linear regression equation derived from the intervention studies, the apparent increase in daily folate consumption due to fortification was calculated.
Statistics
The disparity in the way the data were presented among the published studies precluded the calculation of CIs or further statistical analysis and resulted in the need to use both median and geometric mean values. However, variations between median or geometric mean values were considered sufficiently minor so as to not bias our conclusions. For example, the differences between the median and geometric mean serum folate concentrations in 2 studies conducted by our laboratory (n = 179 and 358) was < 2.5% (SR Davis, EP Quinlivan, LB Bailey, JF Gregory, unpublished observations, 2002). The analyses were conducted by using DATA DESK 5.0.1 software (Data Description Inc, Ithaca, NY).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
), a positive linear correlation (n = 12 data points; r = 0.984, P < 0.0001) was observed between the median or adjusted mean change in serum or plasma folate concentrations and daily folic acid consumption (Figure 1). In all 4 studies, subjects had fasted before blood collection.
|
|
) suggests that an increase in folic acid intake of 70–130 µg/d, the increase the FDA predicted would result from fortification (2), would induce an increase in serum or plasma folate concentration of between 1.9 and 3.5 µg/L. However, all 3 observational studies found far larger increases in serum or plasma folate concentrations after the introduction of fortification (1,17,18). Results from the Framingham Offspring study (1) show that the geometric mean increase in fasting plasma folate concentration was 5.4 µg/L for nonsupplemented subjects (n = 248) sampled between January 1991 and December 1994 and again between September 1997 and March 1998. Similarly, the median serum folate concentration of routine samples measured by a laboratory in California (17) increased by 6.0 µg/L between 1994–1995 (n = 29 243) and 1998 (n = 26 662). Reverse prediction using the regression equation derived in Figure 1 suggests that folate consumption increased in these study groups by 215–240 µg/d, respectively—values approximately twice that predicted by the FDA. Similarly, the 7.9-µg/L increase in serum folate concentration observed (18) in nonsupplemented women between the third National Health and Nutrition Examination Survey (NHANES III, 1988 to1994) and the 1999 NHANES suggests that folate consumption increased by > 200 µg/d. However, a more precise estimate of the increase was not possible because the results were not adjusted to reflect the fact that serum folate concentrations are not normally distributed.
No information was provided on whether subjects in either the Southern California (17) or the NHANES (18) studies were fasted; subjects in the Framingham Offspring study (1) had fasted for 10 h before blood was drawn. Data concerning supplement use in the Southern California study were unavailable (17). Data from both the Framingham Offspring (1) and NHANES (18) studies were for subgroups within the studies who did not use supplements.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Factors affecting predicted and actual intake of fortified foods
The increase in folic acid consumption due to fortification (> 200 µg/d) reported here greatly exceeds the 70–130-µg/d range predicted by the FDA (2). However, our observations are consistent with a growing body of both anecdotal and empirical evidence (7–9,20) that suggests that the effect of folic acid fortification on folic acid intake has exceeded original predictions. This discrepancy may be due in part to wide-scale overfortification. Initial studies suggest that fortified foods typically contain 160% (9) to 175% (7) of their predicted folate content. Similarly, although the FDA made allowances (2) for the fact that most food surveys underreport food intake (21), such bias still represents an inestimable margin of error. Disparities in reportage between food surveys may thus account for the variation in predicted folate intakes observed between studies (2,8,20).
What is the significance of the current folic acid intake
Because the main motivation behind fortification was to prevent NTDs (2), this program has been at least partially successful, as indicated by the reported 19% reduction in NTD incidence (6). It is too early to determine what other health benefits mandatory fortification may have, such as possible reductions in the rates of vascular disease (4) and certain cancers (5). The conclusion of our study is that the benefits that accrue from fortification are a result of a far larger increase in folate consumption than that envisioned—twice the amount originally deemed safe by the FDA (2).
The FDA-mandated fortification level was chosen (2) to maximize folate consumption by women of childbearing age while minimizing the risk of high-folate consumers consuming > 1 mg/d folate, ie, the safe upper limit of intake set by the FDA. However, at least one estimate (8) suggests that between 0.5% and 5% of adults, depending on age and sex, consume > 1 mg folic acid/d based on the FDA’s fortification protocol. Had actual food analysis values (7,9) been used to calculate total folate consumption (natural folate + folic acid), the percentage of people consuming > 1 mg total folate/d (2) would have been higher. This situation is further complicated by the finding that many breakfast cereals are significantly overfortified with folic acid (7,9) and are typically consumed in amounts twice the labeled serving size (7). Thus, an individual could easily exceed the FDA’s safe upper limit of intake (1 mg folic acid/d) by eating just one typical serving of superfortified cereal (labeled as 400 µg/30 g). Because breakfast cereals were commonly fortified before mandatory fortification, their use would not contribute to the increase in folate consumption accruing to fortification but would contribute to one’s daily folate consumption, predominantly as folic acid.
Although small doses of oral folic acid are efficiently metabolized to 5-methyltetrahydrofolate before entering the portal blood, intakes > 200 µg appear to overload this metabolic capacity, leading to the appearance of unmetabolized folic acid in plasma (22). In view of this phenomenon, the current net folic acid intake ( 200 µg/d) is likely to lead to a chronic presence of unmetabolized folic acid in the blood, as was observed previously (23). Delivery of folic acid to tissue could, theoretically, be detrimental because of possible circumvention of normal homeostatic regulation of the cellular retention and metabolic function of folate. 5-Methyltetrahydrofolate, the major form of folate found in serum (24), must be metabolized to tetrahydrofolate before it can be retained by the cell as a polyglutamate (25) or before it can be converted to other folate coenzymes (26). Methionine synthase (EC 2.1.1.13) is the only enzyme to utilize 5-methyltetrahydrofolate as substrate; thus, modulation of that enzyme’s activity may be one mechanism by which folate homeostasis is regulated (25,27). Because cobalamin (vitamin B-12) is a coenzyme for methionine synthase (28), cobalamin deficiency can retard methionine synthase activity, causing a concomitant folate deficiency in cells (29) and disruption of the biosynthetic pathways that utilize folate as substrate (26), ie, purine and thymidine synthesis. In contrast, on entering the cell, folic acid can be retained and subsequently metabolized independently of methionine synthase and cobalamin. The first indicator of cobalamin deficiency is often the resulting folate deficiency, ie, megaloblastic anemia. However, because folic acid is retained and metabolized independently of cobalamin, a high intake of folic acid may prevent the accompanying folate deficiency (30), possibly delaying diagnosis of the underlying cobalamin deficiency, even to a point where irreversible neurologic damage has occurred.
The FDA’s conclusion that folic acid fortification was unlikely to perturb antifolate drug therapies (2) was based on the limited data then available. This conclusion should be reassessed in view of recent studies that suggest that folic acid decreases the antiinflammatory efficacy of methotrexate (31) and that newer antifolate drugs appear more sensitive to perturbation (32).
Use of total plasma homocysteine as a biomarker of folate intake and status
The total plasma homocysteine concentration, nominally a good biomarker of folate intake and status, typically reaches a plateau when dietary folate is supplemented with 200 µg folic acid/d (10,15). This threshold may explain why the decrease in plasma homocysteine due to fortification was not commensurate with the change in plasma folate concentration (Table 2), because the relative change in homocysteine concentration would differ between those consuming > 200 µg folic acid/d and those consuming less. The further decrease in homocysteine concentrations in subjects taking B vitamin supplements (1) may reflect the distinct homocysteine-lowering effect of other components of the multivitamin, ie, cobalamin (33–35), vitamin B-6 (34,35), or riboflavin (35,36).
|
Shortly after the acceptance of this article, Choumenkovitch et al (40) reported estimates of folic acid intake due to fortification. Their study involved the use of a database containing > 105 fortified foods (9) and food-frequency questionnaires form the Framingham Offspring study. Choumenkovitch et al estimated that folic acid consumption increased by 190 µg/d in the Framingham group as a result of fortification. This increase is similar to that which we estimated (215 µg folic acid/d) for the Framingham cohort. Their slightly lower value may be due to disparities in sample groups between the 2 studies or because the use of food-frequency questionnaires may have slightly underestimated food consumption (21).
|
ACKNOWLEDGMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
-glutamate synthetase. 4. In vitro and in vivo metabolism of folates and analogues and regulation of folate homeostasis. Biochemistry 1987;26:530–9.[Medline]
This article has been cited by other articles:
|
|
 |
|
  T. Dervieux Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false-positive report probability Rheumatology, June 1, 2009; 48(6): 597 - 598. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Selhub, M. S. Morris, P. F Jacques, and I. H Rosenberg Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency Am. J. Clinical Nutrition, February 1, 2009; 89(2): 702S - 706S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ganji and M. R. Kafai Demographic, Lifestyle, and Health Characteristics and Serum B Vitamin Status Are Determinants of Plasma Total Homocysteine Concentration in the Post-Folic Acid Fortification Period, 1999-2004 J. Nutr., February 1, 2009; 139(2): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C Hamner, J. Mulinare, M. E Cogswell, A. L Flores, C. A Boyle, C. E Prue, C.-Y. Wang, A. L Carriquiry, and O. Devine Predicted contribution of folic acid fortification of corn masa flour to the usual folic acid intake for the US population: National Health and Nutrition Examination Survey 2001-2004 Am. J. Clinical Nutrition, January 1, 2009; 89(1): 305 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ganji and M. R Kafai Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in the post-folic acid fortification period than in the pre-folic acid fortification period in US adults Am. J. Clinical Nutrition, January 1, 2009; 89(1): 363 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D Kalmbach, S. F Choumenkovitch, A. M Troen, R. D'Agostino, P. F Jacques, and J. Selhub Circulating folic acid in plasma: relation to folic acid fortification Am. J. Clinical Nutrition, September 1, 2008; 88(3): 763 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M Winkels, I. A Brouwer, R. Clarke, M. B Katan, and P. Verhoef Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial Am. J. Clinical Nutrition, August 1, 2008; 88(2): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kotsopoulos, K.-J. Sohn, and Y.-I. Kim Postweaning Dietary Folate Deficiency Provided through Childhood to Puberty Permanently Increases Genomic DNA Methylation in Adult Rat Liver J. Nutr., April 1, 2008; 138(4): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A D. Smith, Y.-I. Kim, and H. Refsum Is folic acid good for everyone? Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P Quinlivan and J. F Gregory III Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1773 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pietrzik, Y. Lamers, S. Bramswig, and R. Prinz-Langenohl Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1414 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F Wyckoff and V. Ganji Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1187 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. De Wals, F. Tairou, M. I. Van Allen, S.-H. Uh, R. B. Lowry, B. Sibbald, J. A. Evans, M. C. Van den Hof, P. Zimmer, M. Crowley, et al. Reduction in Neural-Tube Defects after Folic Acid Fortification in Canada N. Engl. J. Med., July 12, 2007; 357(2): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A D. Smith Reply to RJ Berry et al Am. J. Clinical Nutrition, July 1, 2007; 86(1): 268 - 269. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chattopadhyay, R. Tamari, S. H. Min, R. Zhao, E. Tsai, and I. D. Goldman Commentary: A Case for Minimizing Folate Supplementation in Clinical Regimens with Pemetrexed Based on the Marked Sensitivity of the Drug to Folate Availability Oncologist, July 1, 2007; 12(7): 808 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A Hubner, R. D Houlston, and K. R Muir Should folic acid fortification be mandatory? No BMJ, June 16, 2007; 334(7606): 1253 - 1253. [Full Text] [PDF]
|
|
|
|
|
|
Q.-H. Yang, H. K Carter, J. Mulinare, R. Berry, J. Friedman, and J D. Erickson Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002 Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1409 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Steffen, A. R. Folsom, M. Cushman, D. R. Jacobs Jr, and W. D. Rosamond Greater Fish, Fruit, and Vegetable Intakes Are Related to Lower Incidence of Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology Circulation, January 16, 2007; 115(2): 188 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Poo-Prieto, D. B. Haytowitz, J. M. Holden, G. Rogers, S. F. Choumenkovitch, P. F. Jacques, and J. Selhub Use of the Affinity/HPLC Method for Quantitative Estimation of Folic Acid in Enriched Cereal-Grain Products J. Nutr., December 1, 2006; 136(12): 3079 - 3083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lewis, R. M. Harbord, R. Harris, and G. D. Smith Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk. J Natl Cancer Inst, November 15, 2006; 98(22): 1607 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ganji and M. R Kafai Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 989 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G.K. Bentley, W. C. Willett, M. C. Weinstein, and K. M. Kuntz Population-Level Changes in Folate Intake by Age, Gender, and Race/Ethnicity after Folic Acid Fortification Am J Public Health, November 1, 2006; 96(11): 2040 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Sherwood, L. A. Houghton, V. Tarasuk, and D. L. O'Connor One-Third of Pregnant and Lactating Women May Not Be Meeting Their Folate Requirements from Diet Alone Based on Mandated Levels of Folic Acid Fortification J. Nutr., November 1, 2006; 136(11): 2820 - 2826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Robbins, J. M. Tilford, T.M. Bird, M. A. Cleves, J. A. Reading, and C. A. Hobbs Hospitalizations of Newborns With Folate-Sensitive Birth Defects Before and After Fortification of Foods With Folic Acid Pediatrics, September 1, 2006; 118(3): 906 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-A. da Costa, M. D Niculescu, C. N Craciunescu, L. M Fischer, and S. H Zeisel Choline deficiency increases lymphocyte apoptosis and DNA damage in humans Am. J. Clinical Nutrition, July 1, 2006; 84(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Allen New Approaches for Designing and Evaluating Food Fortification Programs J. Nutr., April 1, 2006; 136(4): 1055 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Rader and B. O. Schneeman Prevalence of Neural Tube Defects, Folate Status, and Folate Fortification of Enriched Cereal-Grain Products in the United States Pediatrics, April 1, 2006; 117(4): 1394 - 1399. [Full Text] [PDF]
|
|
|
|
|
|
R. L. Brent and G. P. Oakley Jr The Folate Debate Pediatrics, April 1, 2006; 117(4): 1418 - 1419. [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Ulrich and J. D. Potter Folate supplementation: too much of a good thing? Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 189 - 193. [Full Text] [PDF]
|
|
|
|
|
|
V. Ganji and M. R. Kafai Trends in Serum Folate, RBC Folate, and Circulating Total Homocysteine Concentrations in the United States: Analysis of Data from National Health and Nutrition Examination Surveys, 1988-1994, 1999-2000, and 2001-2002 J. Nutr., January 1, 2006; 136(1): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Troen, B. Mitchell, B. Sorensen, M. H. Wener, A. Johnston, B. Wood, J. Selhub, A. McTiernan, Y. Yasui, E. Oral, et al. Unmetabolized Folic Acid in Plasma Is Associated with Reduced Natural Killer Cell Cytotoxicity among Postmenopausal Women J. Nutr., January 1, 2006; 136(1): 189 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. O. Song, C.-E. Chung, O. K. Chun, and S. Cho Serum Homocysteine Concentration of US Adults Associated with Fortified Cereal Consumption J. Am. Coll. Nutr., December 1, 2005; 24(6): 503 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Shojania Folate Assays Are No Longer Useful as Screening Tests for Malabsorption Syndrome. Now, Iron and B12 Deficiency Are More Common Than Folate Deficiency in Adults with Untreated Celiac Disease. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 3738 - 3738. [Abstract]
|
|
|
|
|
|
M. Dietrich, C. J.P. Brown, and G. Block The Effect of Folate Fortification of Cereal-Grain Products on Blood Folate Status, Dietary Folate Intake, and Dietary Folate Sources among Adult Non-Supplement Users in the United States J. Am. Coll. Nutr., August 1, 2005; 24(4): 266 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H.K. Vogel, S. F. Bolling, R. B. Costello, E. M. Guarneri, M. W. Krucoff, J. C. Longhurst, B. Olshansky, K. R. Pelletier, C. M. Tracy, R. A. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) J. Am. Coll. Cardiol., July 5, 2005; 46(1): 184 - 221. [Full Text] [PDF]
|
|
|
|
|
|
T. L. Yang, J. Hung, M. A. Caudill, T. F. Urrutia, A. Alamilla, C. A. Perry, R. Li, H. Hata, and E. A. Cogger A Long-Term Controlled Folate Feeding Study in Young Women Supports the Validity of the 1.7 Multiplier in the Dietary Folate Equivalency Equation J. Nutr., May 1, 2005; 135(5): 1139 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, L. E. Hebert, P. A. Scherr, and J. A. Schneider Dietary Folate and Vitamin B12 Intake and Cognitive Decline Among Community-Dwelling Older Persons Arch Neurol, April 1, 2005; 62(4): 641 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark, R. J Pawlosky, S. Beblo, M. Murthy, V. P Flanagan, J. Janisse, M. Buda-Abela, H. Rockett, J. E Whitty, R. J Sokol, et al. Status of plasma folate after folic acid fortification of the food supply in pregnant African American women and the influences of diet, smoking, and alcohol consumption Am. J. Clinical Nutrition, March 1, 2005; 81(3): 669 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Quinlivan, S. R. Davis, K. P. Shelnutt, G. N. Henderson, H. Ghandour, B. Shane, J. Selhub, L. B. Bailey, P. W. Stacpoole, and J. F. Gregory III Methylenetetrahydrofolate Reductase 677C->T Polymorphism and Folate Status Affect One-Carbon Incorporation into Human DNA Deoxynucleosides J. Nutr., March 1, 2005; 135(3): 389 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. C. Basset, E. P. Quinlivan, J. F. Gregory III, and A. D. Hanson Folate Synthesis and Metabolism in Plants and Prospects For Biofortification Crop Sci., January 31, 2005; 45(2): 449 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ganji and M. R Kafai Frequent consumption of milk, yogurt, cold breakfast cereals, peppers, and cruciferous vegetables and intakes of dietary folate and riboflavin but not vitamins B-12 and B-6 are inversely associated with serum total homocysteine concentrations in the US population Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1500 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Robien, C. M. Ulrich, J. Bigler, Y. Yasui, T. Gooley, B. Bruemmer, J. D. Potter, and J. P. Radich Methylenetetrahydrofolate Reductase Genotype Affects Risk of Relapse after Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia Clin. Cancer Res., November 15, 2004; 10(22): 7592 - 7598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-I. Kim Will mandatory folic acid fortification prevent or promote cancer? Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Courtemanche, I. Elson-Schwab, S. T. Mashiyama, N. Kerry, and B. N. Ames Folate Deficiency Inhibits the Proliferation of Primary Human CD8+ T Lymphocytes In Vitro J. Immunol., September 1, 2004; 173(5): 3186 - 3192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roncales, M. Achon, F. Manzarbeitia, C. Maestro de las Casas, C. Ramirez, G. Varela-Moreiras, and J. Perez-Miguelsanz Folic Acid Supplementation for 4 Weeks Affects Liver Morphology in Aged Rats J. Nutr., May 1, 2004; 134(5): 1130 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pentieva, H. McNulty, R. Reichert, M. Ward, J. J. Strain, D. J. McKillop, J. M. McPartlin, E. Connolly, A. Molloy, K. Kramer, et al. The Short-Term Bioavailabilities of [6S]-5-Methyltetrahydrofolate and Folic Acid Are Equivalent in Men J. Nutr., March 1, 2004; 134(3): 580 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Bailey Folate, Methyl-Related Nutrients, Alcohol, and the MTHFR 677C->T Polymorphism Affect Cancer Risk: Intake Recommendations J. Nutr., November 1, 2003; 133(11): 3748S - 3753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. V. van Oort, A. Melse-Boonstra, I. A Brouwer, R. Clarke, C. E West, M. B Katan, and P. Verhoef Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1318 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Shane Folate fortification: enough already? Am. J. Clinical Nutrition, January 1, 2003; 77(1): 8 - 9. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
